Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes

scientific article

Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5114/AOMS.2016.60821
P932PMC publication ID5575210
P698PubMed publication ID28883843

P2093author name stringBin Zhou
Xiaohui Zhao
Quan Jiang
Ruihua Chen
Xiaozhen Jiang
P2860cites workDiabetes duration and cause-specific mortality in the Verona Diabetes StudyQ74150687
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetesQ82938218
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerQ24642646
CD36: implications in cardiovascular diseaseQ24678338
Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticityQ26853611
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarctionQ29618673
Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling populationQ33600269
Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36Q33606906
Increased CD36 expression signals monocyte activation among patients with type 2 diabetes.Q34084613
Relationship between single nucleotide polymorphisms in the 3'-untranslated region of the vascular endothelial growth factor gene and susceptibility to diabetic peripheral neuropathy in ChinaQ34466706
CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.Q34471077
Role of CD36, the macrophage class B scavenger receptor, in atherosclerosisQ34496967
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysisQ34604937
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?Q34608998
Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairmentQ35563671
Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expressionQ35840890
Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients with and without microangiopathyQ36105705
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studiesQ36311526
CD36 mediates the innate host response to beta-amyloidQ36370903
Innate immunity receptor CD36 promotes cerebral amyloid angiopathyQ36637524
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complicationsQ36906245
Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican AmericansQ37106597
Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: the CARDIA studyQ37309799
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive functionQ38422040
The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammationQ39876607
Carotid artery atherosclerosis is correlated with cognitive impairment in an elderly urban Chinese non-stroke populationQ40133239
Complications of DiabetesQ42390608
Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes riskQ43170056
Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: a cross-section studyQ44244627
Low BDNF is associated with cognitive deficits in patients with type 2 diabetesQ44345365
Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adultsQ46254739
Relation of diabetes to mild cognitive impairmentQ48210463
PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.Q48273067
The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairmentQ48606051
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population.Q51535629
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.Q53385146
Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque InstabilityQ61066384
15-year longitudinal study of blood pressure and dementiaQ71021081
P433issue5
P304page(s)1031-1039
P577publication date2016-06-22
P1433published inArchives of Medical ScienceQ15753010
P1476titlePlasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes
P478volume13

Reverse relations

cites work (P2860)
Q92276957Resveratrol and cognitive decline: a clinician perspective
Q94454413The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond

Search more.